Imprint cytology of the sentinel lymph node in the assessment of axillary node status in breast carcinoma
Introduction
Sentinel lymph node (SLN) biopsy is now well established in breast cancer surgery. A SLN free of tumour could eliminate the need for lymph node clearance in suitable patients, avoiding an unnecessary procedure with its associated morbidity.1 Routine assessment of paraffin-wax sections of SLN takes many hours to complete and as a result patients with metastatic tumour in the SLN will have to be recalled for an axillary clearance. Intra-operative assessment of the SLN status would allow concurrent axillary clearance to be performed in the node-positive patients and also helps to inform the patients of their axillary nodal status immediately after the surgery.
Any method used in such assessment should be quick, so as not to waste theatre time, and reliable, to avoid unacceptable levels of false-positive or false-negative results. A false-negative result (missed metastatic tumour in the SLN) will result in the patient being recalled for further surgery after earlier reassurance that this would probably not be necessary. A false-positive result (metastatic tumour diagnosed where in fact there was no tumour) will result in a normal axilla being cleared of lymph nodes. At present only two methods appear to have a role in the intra-operative identification of the SLN status: frozen section histology and imprint cytology.
The role of frozen section histology has been assessed in a number of studies but the problem with most studies had been a lack of sensitivity due to high false-negative rates, as high as 48%.2., 3. One way to reduce this problem might be to examine the entire sentinel node by taking multiple sections, as reported by Veronesi's group from Milan.4 Having reported a false-negative rate of 36% with routine frozen sections previously5 they eliminated this problem by examining 60 frozen sections per node and by using both haematoxylin and eosin (H & E) stained sections and immunohistochemistry. Most would agree that this is neither practical in the intra-operative setting nor cost effective for most pathology laboratories. Frozen section examination also results in the loss of a large amount of lymph node tissue and in freeze-thaw artefact in the remaining tissue, both compromising the subsequent paraffin-wax section assessment.
Imprint cytology, on the other hand, is simple, relatively quick and inexpensive and does not result in any loss of nodal tissue. A number of recent studies have suggested that imprint cytology allows most patients who require an axillary clearance to be identified intra-operatively.6., 7., 8., 9., 10. Here we have studied the role of imprint cytology in the assessment of SLN status.
Section snippets
Patients and methods
Female patients with both screen-detected and symptomatic breast carcinoma underwent SLN biopsy as part of their definitive surgical treatment at the breast unit of the Norfolk and Norwich University Hospital over a 20-month period. The SLN was identified either by using only the Patent blue V dye (Guerbet Laboratories Ltd, Milton Keynes, UK) or a combination of dye and isotope (Nanocoll, Nycomed Amersham, Bucks, UK). Isotope and the dye were injected subdermally over the tumour (in case of
Results
During the study period SLN biopsy was attempted in 139 patients with invasive breast carcinoma. Blue dye alone was used in 119 patients and dye and isotope in 20 patients. The SLN was identified in 133 patients (96%) and these patients constitute the study population. The mean age of these patients was 60.4 years (range 28–87). Twenty-seven patients had impalpable tumours. The mean size of the tumours preoperatively was 18.6 mm. The mean time for SLN biopsy was 9 min (range 2–24). Fifty-one
Discussion
Intra-operative assessment of the SLN status may enable the surgeon to complete the breast cancer surgery in one sitting in most patients, avoiding the risks and cost as well as patient anxiety associated with a second operation. This work suggests that imprint cytology accurately reflects the lymph node from which it was taken. The commonest reason for false-negative imprint results was the presence of small metastases away from the bisected surface of the node. This is recognised11 but was
Acknowledgements
We would like to thank Mr S.D. Scott for contributing patients to the study and Dr Skrypniuk for scintigrams. We acknowledge the assistance of Professor Ell and Mr Keshtgar from the Department of Nuclear Medicine and Surgery, University College Hospital, in establishing the sentinel lymph node technique in Norwich.
References (18)
- et al.
Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes
Lancet
(1997) - et al.
A trend analysis of the relative value of blue dye and isotope localisation in 2000 consecutive cases of sentinel node biopsy for breast cancer
J Am Coll Surg
(2001) - et al.
Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania
Cancer
(2002) - et al.
Intraoperative sentinel lymph node examination by imprint cytology and frozen sectioning during breast surgery
Br J Surg
(2000) - et al.
Accuracy of intraoperative frozen section analysis of axillary nodes
Br J Surg
(1999) - et al.
Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients
Cancer
(1999) - et al.
Intraoperative assessment of sentinel lymph nodes in patients with breast carcinoma. Accuracy of rapid imprint cytology compared with definitive histologic workup
Cancer (Cancer Cytopathol)
(2002) - et al.
Intraoperative touch imprint of sentinel lymph nodes in breast carcinoma patients
Cancer (Cancer Cytopathol)
(2002) - et al.
Intraoperative sentinel lymph node examination by imprint cytology during breast surgery
Curr Med Res Opin
(2002)
Cited by (16)
Intra-operative imprint cytology for assessing the sentinel node in breast cancer - Results of its routine use over 8 years
2009, European Journal of Surgical OncologyCitation Excerpt :None of the false negatives were due to cells from lobular carcinoma being mistaken for lymphoid cells as has been described previously.11, 12 The reported sensitivity of IIC using lymph node bisection (the technique used in this study) in previous research studies ranges from 41% to 86%4,9,13–17 (Table 2). However, time and economic and other pressures may vary significantly between normal clinical practice and a research setting.
Patients' view on intraoperative diagnosis of sentinel nodes in breast cancer: Is it an automatic choice?
2007, International Journal of SurgeryCitation Excerpt :This emphasizes the need to ensure that patients understand the potential for a false negative result and have realistic expectations of what can be achieved at their treating hospital. False positive diagnoses have been reported for both frozen section and touch imprint cytology, which could lead to unnecessary extensive surgery (ALND).6–8 There were no false positive diagnoses in this study.
Accuracy of intraoperative imprint cytology of sentinel lymph nodes in breast cancer
2006, American Journal of SurgeryCitation Excerpt :Intraoperative IC allowed 49 (55%) of the N1 or greater patients to benefit from synchronous ALND. Previous series examining the accuracy of intraoperative IC have reported sensitivities ranging from as low as 34% to as high as 96% [3,14–21]. Table 2 shows a summary of our review of the English literature.
Lymphatic mapping in management of patients with primary cutaneous melanoma
2005, Lancet OncologyCitation Excerpt :Intraoperative frozen-section examination of sentinel nodes in patients with melanoma has been abandoned in most centres because of high rates of false-negatives.75 However, other methods of rapid intraoperative sentinel-node assessment, such as examination of fine-needle aspirates by use of magnetic resonance spectroscopy, are being investigated,76 as is the accuracy of imprint cytology in patients having sentinel-node biopsy for breast cancer.77,78 Interim results of the first Multicenter Selective Lymphadenectomy Trial,3,68,79 suggest that sentinel-node biopsy, with immediate completion regional-node dissection if micrometastatic disease is found in a sentinel node, improves survival for patients who are node-positive.
Intraoperative evaluation of sentinel lymph nodes for breast cancer
2005, Breast Diseases